U.S. Colorectal Cancer Screening Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2024 - 2031)

U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of U.S. Colorectal Cancer Screening Market

Les principaux acteurs du marché américain du dépistage du cancer colorectal sont Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Myriad Genetics Inc., QIAGEN, Merck KGaA

U.S. Colorectal Cancer Screening Market Leaders

  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Société Sysmex
  • Société Quidel
  • Novigenix SA
*Disclaimer: Major players are listed in no particular order.

U.S. Colorectal Cancer Screening Market - Competitive Rivalry, 2023

Market Concentration Graph

U.S. Colorectal Cancer Screening Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

U.S. Colorectal Cancer Screening Market Report Snapshots

Buy Now